首页> 外文期刊>Journal of Korean Neurosurgical Society >Prospective Comparison of Redo Microvascular Decompression and Percutaneous Balloon Compression as Primary Surgery for Recurrent Trigeminal Neuralgia
【24h】

Prospective Comparison of Redo Microvascular Decompression and Percutaneous Balloon Compression as Primary Surgery for Recurrent Trigeminal Neuralgia

机译:重做微血管减压术和经皮球囊加压术作为三叉神经再发性复发的主要手术方法的前瞻性比较

获取原文
           

摘要

Objective To prospectively compare facial pain outcomes for patients having either a repeat microvascular decompression (MVD) or percutaneous balloon compression (PBC) as their surgery for trigeminal neuralgia (TN) recurrence. Methods Prospective cohort study of 110 patients with TN recurrence who had either redo MVD (n=68) or PBC (n=42) from July 2010 until September 2016. The mean follow-up was 45.6 months. Results After redo MVD, 65 patients (95.6%) experienced immediate relief of pain. After PBC, 34 patients (81%) were immediately relieved of their neuralgia. After 1 month, the clinical effect of redo MVD was better than PBC ( p 0.05). Patients after PBC who occurred developed herpes simplex (35.7%), facial numbness (76.2%), and annoying dysesthesia (21.4%) more frequently compared with patients after redo MVD who occurred developed herpes simplex (14.7%), facial numbness (8.8%), and hypoesthesia (5.9%) ( p 0.05). The symptoms recurred respectively in 15 patients (22.1%) and 19 patients (45.2%) after redo MVD and PBC within the entire 6-year follow-up period. Conclusion For the patients with TN recurrence, redo MVD was a more effective procedure than PBC. The cure rate and immediate relief of pain were better, and the incidence of complications was lower.
机译:目的前瞻性比较三叉神经痛(TN)复发的反复微血管减压(MVD)或经皮球囊加压(PBC)患者的面部疼痛结局。方法从2010年7月至2016年9月,对110例重做MVD(n = 68)或PBC(n = 42)的TN复发患者进行前瞻性队列研究。平均随访时间为45.6个月。结果重做MVD后,有65例患者(95.6%)立即疼痛得到缓解。 PBC后,有34名患者(81%)立即解除了神经痛。 1个月后,重做MVD的临床效果优于PBC(p 0.05)。与重做MVD后发生单纯疱疹(14.7%),面部麻木(8.8%)相比,发生PBC后发生单纯疱疹(35.7%),面部麻木(76.2%)和烦躁的感觉异常(21.4%)的频率更高。 )和感觉不足(5.9%)(p <0.05)。在整个6年的随访期内,MVD和PBC重做后分别有15例(22.1%)和19例(45.2%)复发。结论对于TN复发患者,MVD重做比PBC更有效。治愈率和疼痛的立即缓解效果更好,并发症的发生率更低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号